# Predicting the Efficacy in Advanced Gastric Cancer.

> **NCT06490055** · — · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 162 (actual)

## Conditions studied

- Gastric Cancer
- Chemotherapy Effect
- Paclitaxel
- Ramucirumab

## Interventions

- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT06490055
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2025-02-18
- **Final completion:** 2025-07-01
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06490055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06490055, "Predicting the Efficacy in Advanced Gastric Cancer.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06490055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*